glp 1 gip glucagon LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Role of a Dual Glucose-Dependent
Description
Some weight regain is common, especially if old eating habits reemerge
But thats not the only thing that helps keep the weight off
Diabetes 58 (2), 403411
For Wegovy, this titration extends over 16-20 weeks
